WKN: | A403M5 |
ISIN: | FR001400NLM4 |
Land: | Frankreich |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Gesundheit |
Weshalb die Orpea-Aktie
ein D-Rating hat,
erfahren Sie im Performance-Check
vom 07. August 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2025 | 5,75 | 12,95 | 125,22% |
2 | 2005 | 746,92 | 1.353,00 | 81,14% |
3 | 2004 | 482,73 | 746,92 | 54,73% |
4 | 2006 | 1.353,00 | 2.093,39 | 54,72% |
5 | 2015 | 3.309,87 | 4.676,50 | 41,29% |
6 | 2003 | 361,75 | 482,73 | 33,44% |
7 | 2012 | 1.585,84 | 2.103,83 | 32,66% |
8 | 2019 | 5.542,48 | 7.283,72 | 31,42% |
9 | 2017 | 4.838,63 | 6.242,47 | 29,01% |
10 | 2013 | 2.103,83 | 2.655,79 | 26,24% |
11 | 2007 | 2.093,39 | 2.621,19 | 25,21% |
12 | 2014 | 2.655,79 | 3.309,87 | 24,63% |
13 | 2009 | 1.536,54 | 1.839,58 | 19,72% |
14 | 2010 | 1.839,58 | 2.032,31 | 10,48% |
15 | 2016 | 4.676,50 | 4.838,63 | 3,47% |
16 | 2020 | 7.283,72 | 6.816,98 | -6,41% |
17 | 2018 | 6.242,47 | 5.542,48 | -11,21% |
18 | 2021 | 6.816,98 | 5.555,18 | -18,51% |
19 | 2011 | 2.032,31 | 1.585,84 | -21,97% |
20 | 2008 | 2.621,19 | 1.536,54 | -41,38% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2023 | 381,01 | 18,60 | -95,12% |
2 | 2022 | 5.555,18 | 381,01 | -93,14% |
3 | 2024 | 18,60 | 5,75 | -69,09% |
4 | 2008 | 2.621,19 | 1.536,54 | -41,38% |
5 | 2011 | 2.032,31 | 1.585,84 | -21,97% |
6 | 2021 | 6.816,98 | 5.555,18 | -18,51% |
7 | 2018 | 6.242,47 | 5.542,48 | -11,21% |
8 | 2020 | 7.283,72 | 6.816,98 | -6,41% |
9 | 2016 | 4.676,50 | 4.838,63 | 3,47% |
10 | 2010 | 1.839,58 | 2.032,31 | 10,48% |
11 | 2009 | 1.536,54 | 1.839,58 | 19,72% |
12 | 2014 | 2.655,79 | 3.309,87 | 24,63% |
13 | 2007 | 2.093,39 | 2.621,19 | 25,21% |
14 | 2013 | 2.103,83 | 2.655,79 | 26,24% |
15 | 2017 | 4.838,63 | 6.242,47 | 29,01% |
16 | 2019 | 5.542,48 | 7.283,72 | 31,42% |
17 | 2012 | 1.585,84 | 2.103,83 | 32,66% |
18 | 2003 | 361,75 | 482,73 | 33,44% |
19 | 2015 | 3.309,87 | 4.676,50 | 41,29% |
20 | 2006 | 1.353,00 | 2.093,39 | 54,72% |